PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Hirai H [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. 2004 Nippon Yakurigaku Zasshi pmid:14695454
Uehara Y [PGD(2)/L-PGDS system in hypertension and renal injury]. 2004 Nippon Yakurigaku Zasshi pmid:14695455
Miwa Y et al. Physiology and pharmacology of the prostaglandin J2 family. 2004 Nippon Yakurigaku Zasshi pmid:14695456
Arai I [Role of cutaneous prostaglandin D2 production on scratching dermatitis in mice]. 2006 Nippon Yakurigaku Zasshi pmid:17167214
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Urade Y [New aspects on prostaglandin D synthases]. 1997 Nippon Yakurigaku Zasshi pmid:9503406
Ushikubi F and Narumiya S [The roles of the prostanoids played in the body]. 2002 Nippon Yakurigaku Zasshi pmid:11979724
Sonoki H et al. [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. 1988 Nippon Yakurigaku Zasshi pmid:3163668
Onoe H [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. 1998 Nippon Yakurigaku Zasshi pmid:10202759
Satoh T [Neurotrophin-like low molecular weight compounds]. 2002 Nippon Yakurigaku Zasshi pmid:12491808
Kikuchi Y et al. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2313142
Kikuchi Y et al. Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro. 1987 Nippon Sanka Fujinka Gakkai Zasshi pmid:3479504
Masuko-Hongo K [Role of prostaglandins in rheumatoid arthritis]. 2005 Nippon Rinsho pmid:15799333
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Uehara Y [Prostaglandin D2]. 1999 Nippon Rinsho pmid:10635955
Uehara Y [Prostaglandin D2 and related substances]. 2010 Nippon Rinsho pmid:20960740
Fukushima S et al. [Pharmaceutical and pharmacological development of antitumor prostaglandins]. 1998 Nippon Rinsho pmid:9549353
Uehara Y [Prostaglandin D2]. 2005 Nippon Rinsho pmid:16149440
Hayaishi O [Prostaglandins and sleep]. 1998 Nippon Rinsho pmid:9503823
Urade Y [Gene engineering studies on sleep]. 1998 Nippon Rinsho pmid:9503856
Uchizono K [Studies of sleep inducing substance]. 1984 Nippon Rinsho pmid:6384575
Urade Y [Molecular mechanisms of insomnia]. 2009 Nippon Rinsho pmid:19768929
Saito H [Mast cells]. 2005 Nippon Rinsho pmid:15861652
Fukushima M [Prostaglandin J2--anti-tumor activity and mechanism of action]. 1988 Nippon Rinsho pmid:3043050
Nagata N and Urade Y [Endogenous sleep-promoting substance]. 2012 Nippon Rinsho pmid:22844810
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Kariya T et al. Platelet abnormality with no response to PGD2 in a patient with metastatic pancreas carcinoma and myeloproliferative disorder. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3473883
Mezawa A [Nasal response to chemical mediators in nasal allergy]. 1988 Nippon Jibiinkoka Gakkai Kaiho pmid:3199260
Shiroma T et al. [Production and metabolism of prostaglandin D2 by cultured chick retinal pigment epithelial cells]. 1996 Nippon Ganka Gakkai Zasshi pmid:8741332
Goto H [Quantitative determination of prostaglandin D2 in the rat gastric mucosa by high performance liquid chromatography]. 1987 Nihon Shokakibyo Gakkai Zasshi pmid:3473244
Shimojima T et al. [Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]. 1987 Nihon Shishubyo Gakkai Kaishi pmid:2851629
Fujitani Y et al. [Sleep-promoting substances]. 1998 Nihon Ronen Igakkai Zasshi pmid:10064966
Yamada K [The effect of prostaglandin D2 on rat testicular testosterone levels]. 1989 Nihon Naibunpi Gakkai Zasshi pmid:2591605
Suzuki H et al. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. 1986 Nihon Naibunpi Gakkai Zasshi pmid:3465609
Kudo M et al. [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells]. 1990 Nihon Naibunpi Gakkai Zasshi pmid:1962750
Hoshi A et al. [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. 1992 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1507684
Fukuda T [Trend in chemical mediator research in asthma and its application for asthma treatment]. 2003 Nihon Kokyuki Gakkai Zasshi pmid:14531291
Ehara H [An experimental study on antitumor effect of prostaglandin D2]. 1989 Nihon Geka Gakkai Zasshi pmid:2796985
Nishimura G [Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. 1990 Nihon Gan Chiryo Gakkai Shi pmid:2351856
Sakai T [Molecular cancer epidemiology--the present status and future possibilities]. 1996 Nihon Eiseigaku Zasshi pmid:8720930
Liu H et al. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. 2013 Neurotoxicology pmid:23973622
Toscano CD et al. NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. 2008 Neurotoxicology pmid:18834901
Shohami E et al. Experimental closed head injury in rats: prostaglandin production in a noninjured zone. 1988 Neurosurgery pmid:3164097
Hayaishi O and Urade Y Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. 2002 Neuroscientist pmid:11843094
Vesin MF et al. Biosynthesis of prostaglandin D2 by motoneurons and dorsal horn microneurons: a biochemical and high resolution immunocytochemical study in chick spinal cord. 1995 Neuroscience pmid:8596663
Liu M et al. Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. 2007 Neuroscience pmid:17241746
Telleria-Diaz A et al. Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. 2008 Neuroscience pmid:18678231
Zurich MG et al. Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. 2005 Neuroscience pmid:15994020
Pena-dos-Santos DR et al. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. 2009 Neuroscience pmid:19647045
Horiguchi T et al. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. 2006 Neuroscience pmid:16567054
Satoh S et al. Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. 1994 Neurosci. Res. pmid:7708292
Osaka T and Hayaishi O Prostaglandin D2 modulates sleep-related and noradrenaline-induced activity of preoptic and basal forebrain neurons in the rat. 1995 Neurosci. Res. pmid:8545074
Govoni S et al. The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. 2001 Neurosci. Lett. pmid:11311500
Leamy AW et al. Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. 2011 Neurosci. Lett. pmid:21855605
Nakae K et al. Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. 2005 Neurosci. Lett. pmid:16039053
Wu L et al. Divergent effects of prostaglandin receptor signaling on neuronal survival. 2007 Neurosci. Lett. pmid:17574754
Kitamura Y et al. Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. 1999 Neurosci. Lett. pmid:10203248
Marchini C et al. Aspirin modulates LPS-induced nitric oxide release in rat glial cells. 2005 Jun 10-17 Neurosci. Lett. pmid:15882795
Ott D et al. Prostaglandin D2 modulates calcium signals induced by prostaglandin E2 in neurons of rat dorsal root ganglia. 2015 Neurosci. Lett. pmid:25912777
Myeku N et al. cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. 2012 Neurosci. Lett. pmid:22982149
Inoué S et al. Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. 1984 Neurosci. Lett. pmid:6593603
Rohn TT et al. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. 2001 Neuroreport pmid:11277593
Yoshida Y et al. Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2. 2000 Neuroreport pmid:10923657
Terao A et al. Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. 1998 Neuroreport pmid:9875706
Horváth B et al. Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. 2008 Neuroreport pmid:18815586
García-Bueno B et al. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. 2007 Neuropsychopharmacology pmid:17119541
Bate C et al. Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. 2006 Neuropharmacology pmid:16289250
Grill M et al. Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. 2006 Neuropharmacology pmid:16182321
Costello DA et al. Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. 2005 Neuropharmacology pmid:15993441
Morgenweck J et al. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. 2010 Neuropharmacology pmid:19891980
Kaneko K et al. Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. 2012 Neuropeptides pmid:23141054
Urade Y et al. Sleep regulation in adenosine A2A receptor-deficient mice. 2003 Neurology pmid:14663019
Dore-Duffy P et al. Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. 1991 Neurology pmid:1992386
Cho WH et al. 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. 2006 Neurochem. Res. pmid:17006759
Gotoh M et al. Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes. 1994 Neurochem. Res. pmid:8065525
Tsuji T et al. Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. 2009 Neurochem. Res. pmid:18946735
Li W et al. Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. 2008 Neurochem. Res. pmid:17763946
Naffah-Mazzacoratti MG et al. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. 1995 Neurochem. Int. pmid:8574174
Flores JJ et al. PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. 2016 Neurobiol. Dis. pmid:26739391
Ogburn KD et al. Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. 2006 Neurobiol. Dis. pmid:16406650
Liu H et al. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. 2011 Neurobiol. Dis. pmid:20933087
Kootte AM et al. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. 1983 Neth J Med pmid:6572798
Lu Y et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells. 2013 Nephron Exp. Nephrol. pmid:23887394
Lee S et al. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. 2006 Nephrol. Dial. Transplant. pmid:16728429
Li X et al. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. 2007 Nephrol. Dial. Transplant. pmid:17255125
Panzer U et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. 2008 Nephrol. Dial. Transplant. pmid:18596134
Kimura H et al. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. 2008 Nephrol. Dial. Transplant. pmid:18367541
Prakash J et al. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. 2009 Neoplasia pmid:20019843
Wang JP et al. Anti-inflammatory and analgesic effects of magnolol. 1992 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1336574
Molderings GJ et al. Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors. 1998 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9826066
Featherstone RL et al. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha. 1990 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2142256
Hsu MF et al. Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. 2004 Naunyn Schmiedebergs Arch. Pharmacol. pmid:15083266
Ricote M et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. 1998 Nature pmid:9422508
Jiang C et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. 1998 Nature pmid:9422509
Rossi A et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. 2000 Nature pmid:10638762
Luster AD and Tager AM T-cell trafficking in asthma: lipid mediators grease the way. 2004 Nat. Rev. Immunol. pmid:15343370
Wang C et al. A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. 2014 Nat. Methods pmid:24292485
Gilroy DW et al. Inducible cyclooxygenase may have anti-inflammatory properties. 1999 Nat. Med. pmid:10371510
Taketomi Y et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. 2013 Nat. Immunol. pmid:23624557
Starkl P et al. PLA2G3 promotes mast cell maturation and function. 2013 Nat. Immunol. pmid:23685814